Welcome to the RfB

EurA1c, the trial exploring the effectiveness of HbA1c tests across various countries and manufacturers, was conducted for the seventh time in 2022. Over 4,000 laboratories in 22 countries participated. The report is now available on our website.

The pilot survey for antigen detection of Legionella pneumophila in urine (LegAg) was successfully completed and showed a gratifyingly high number of participants.

 The RfB has decided to include this EQA scheme in the semi-annual external quality assurance programme.

The next survey will take place on 09.10.2023 until 21.10.2023.
Please note the registration deadline of 14.08.2023.
You can register as usual via your participant account at www.rfb.bio.

 Attachment
We look forward to your participation.

With kind regards
Your RfB Team